CancerVax Raises $72 Million in IPO

CancerVax Corp., a Carlsbad company that is developing cancer treatments, raised $72 million in an initial public offering, selling 6 million shares at $12 each, at the bottom of the $12-to-$14-a-share price range the company had indicated in a Securities and Exchange Commission filing.

CancerVax is testing a treatment for skin cancer.